U.S. markets open in 2 hours 9 minutes
  • S&P Futures

    3,428.75
    -3.50 (-0.10%)
     
  • Dow Futures

    28,132.00
    -50.00 (-0.18%)
     
  • Nasdaq Futures

    11,649.00
    -11.75 (-0.10%)
     
  • Russell 2000 Futures

    1,612.10
    -2.70 (-0.17%)
     
  • Crude Oil

    40.98
    -0.72 (-1.73%)
     
  • Gold

    1,922.60
    +7.20 (+0.38%)
     
  • Silver

    25.14
    +0.16 (+0.64%)
     
  • EUR/USD

    1.1868
    +0.0039 (+0.33%)
     
  • 10-Yr Bond

    0.7970
    0.0000 (0.00%)
     
  • Vix

    29.96
    +0.78 (+2.67%)
     
  • GBP/USD

    1.3050
    +0.0104 (+0.80%)
     
  • USD/JPY

    104.8650
    -0.6050 (-0.57%)
     
  • BTC-USD

    12,219.37
    +1,162.36 (+10.51%)
     
  • CMC Crypto 200

    245.56
    +6.65 (+2.78%)
     
  • FTSE 100

    5,820.90
    -68.32 (-1.16%)
     
  • Nikkei 225

    23,639.46
    +72.42 (+0.31%)
     

GILD vs. TECH: Which Stock Should Value Investors Buy Now?

Zacks Equity Research

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Gilead Sciences (GILD) or Techne (TECH). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.

Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.

Gilead Sciences has a Zacks Rank of #2 (Buy), while Techne has a Zacks Rank of #3 (Hold) right now. This means that GILD's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. But this is just one piece of the puzzle for value investors.

Value investors also try to analyze a wide range of traditional figures and metrics to help determine whether a company is undervalued at its current share price levels.

The Style Score Value grade factors in a variety of key fundamental metrics, including the popular P/E ratio, P/S ratio, earnings yield, cash flow per share, and a number of other key stats that are commonly used by value investors.

GILD currently has a forward P/E ratio of 9.27, while TECH has a forward P/E of 44.48. We also note that GILD has a PEG ratio of 3.79. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. TECH currently has a PEG ratio of 4.04.

Another notable valuation metric for GILD is its P/B ratio of 3.96. The P/B ratio is used to compare a stock's market value with its book value, which is defined as total assets minus total liabilities. For comparison, TECH has a P/B of 7.08.

Based on these metrics and many more, GILD holds a Value grade of A, while TECH has a Value grade of D.

GILD stands above TECH thanks to its solid earnings outlook, and based on these valuation figures, we also feel that GILD is the superior value option right now.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Gilead Sciences, Inc. (GILD) : Free Stock Analysis Report
 
Bio-Techne Corp (TECH) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research